Pediatrix Medical Group Inc (NYSE: MD) – Time For Strategy Change?

Pediatrix Medical Group Inc (NYSE:MD) currently has a daily average trading volume of 668.12K but it saw 1097097 shares traded in last market. With a market cap of 1.11B USD, the company’s current market price of $12.88 came rising about 2.55 while comparing to the previous closing price of $12.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $17.67 and as low as $6.62. In the recent trading on the day, stock has struck highest price mark of $12.241 while lowest mark touched by it was $12.945.

Taking a look at 20-day trading activity of Pediatrix Medical Group Inc (MD) gives us an average price of $13.08, while its current price level is -27.11% below from 52-week high level whereas it is 94.56% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $14.00 while that of 200 days or SMA-200 reads an average of $12.76. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.64% during that period while stretching the period over a month that increases to 4.43%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.63 which implies that the stock is in neutral territory.

Jefferies upgraded its recommendation for the stock as a “Buy” from “Hold” on September 26, 2024 while assigning a price target range of $8-$14. Deutsche Bank issued its recommendations for the stock as it upgraded the price target for the stock is $8.

Over the week, MD’s stock price is moving 4.97% up while it is -11.11% when we observe its performance for the past one month. Year-to-date it is -1.83% down and over the past year, the stock is showing an upside performance of 42.48%.

The company is expected to be releasing its next quarterly report on 2025-Feb-19, for which analysts forecasted an EPS of 0.24 while estimate for next year EPS is 1.54. In next quarter, company is expected to be making quarterly sales of $461.87M as analysts are expecting the sales for current fiscal year at $1.86B and seeing the company making $1.92B in sales next year. Moreover, analysts are in estimates of $451.44M for current-quarter revenue.

Currently, Pediatrix Medical Group Inc’s total number of outstanding shares is 85.87M with 1.78% of that held by the insiders while 101.00% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -7.11% and return on equity (ROE) at -12.28%. It has a 7.93 of forward P/E ratio. Stock’s beta reads 1.27. Stock has a price to book (P/B) ratio of 1.45 while price to sale or P/S ratio amounts to 0.55. Its return on asset (ROA) is -4.53% on average.